| Dr. Mel Featured on Walgreen's health segment |
|
|
| Written by JBaileyAdmin | |
| Wednesday, 17 October 2007 | |
|
You may have missed it this past weekend, but Dr. Mel was featured in a health segment produced for Walgreen's drug stores that aired on the Lifetime cable network this past weekend. ![]() Dr. Mel on Walgreens Health segment The segment recaps the treatments Mel has received since he was first diagnosed eleven years ago, including drug trials at the Dana-Farber Cancer Center in Boston. "If it weren't for clinical trials, I wouldn't be here talking with you," he said on the segment.You can catch the segment when it re-airs December 2nd, or you can see it right now on the Walgreens site. |
| < Prev | Next > |
|---|
Multiple Myeloma News Update
-
Reader to Reader: Sept. 4
London Free Press
15, the London and District Multiple Myeloma Support Group held its second annual Dorchester Walk of Champions for myeloma research. ... -
Beacon NewsFlashes – September 3, 2010
The Myeloma Beacon
Revlimid is approved in the US for the treatment of multiple myeloma as well as a collection of blood disorders called myelodysplastic syndromes. ...
Celgene Officially Notified of ANDA Filing for REVLIMID(R)Trading Markets (press release)
Beacon NewsFlashes – September 3, 2010The MDS Beacon
all 32 news articles » -

TheMedGuruLisa Ray Talks On Struggle Against Cancer
Bollywood Non-Stop
The actress has taken multiple myeloma on 23 June 2009 and started her first cycle of treatment for cancer on 2 July 2009. Lisa Ray has announced on April ...
Lisa Ray - Fighting against CancerBreakingNewsOnline.
Lisa Ray talks about breast cancer!FitnHit.com (blog)
After cancer battle, Lisa Ray spreads hopeDaily News & Analysis
MSN India
all 21 news articles » -
GBI Research's report analyzes licensing agreement to shape global market
News-Medical.net
GBI Research's report, "Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and ... -
A Look at Immunogen Beyond the T-DM1 Setback
Seeking Alpha (blog)
The second trial is a phase I in multiple myeloma that will probably be reported at ASH in December. I reviewed earlier results from this trial here. ...
and more » -
Guide To Nutrition In Multiple Myeloma – Part 2: Supplements
The Myeloma Beacon
This article is the second in a two-part series about nutrition for multiple myeloma patients. The first article provides an introduction to nutrition for ...
Pat's Place: A Patient's Reflections On The Progress Of Multiple Myeloma ResearchThe Myeloma Beacon
all 2 news articles » -
Bone morphogenetic protein-2 higher in patients with multiple myeloma
HemOncToday
Results from a recent study showed that bone morphogenetic protein-2 was a mediator for hepcidin-stimulatory capacity in multiple myeloma sera, ... -
NICE backs Thalidomide and Velcade for multiple myeloma
Pharma Times
Celgene's Thalidomide and Janssen-Cilag's Velcade have been recommended as options to treat patients with multiple myeloma on the National Health Service by ...













